Overview

Collagen and Gelatin Market for Regenerative Medicine is anticipated to value over USD 939 million by 2027 end with a CAGR of over 9.9% during the forecast period 2020 to 2027.

The rising incidences of appalling diseases, rapidly increasing geriatric population, increased private and public financial assistance for developing regenerative medicines are some of the key driving factors of the market. Regenerative medicine promotes the potential restoration of injured tissues and organs. Multiple regenerative therapies for cardiovascular diseases, orthopaedic disorders and wound healing have been introduced over the years and have ben approved by the FDA. The usage of gelatin and collagen-based biomaterials in application related to regenerative medicine have been promoted intensely over the past few years. This method is currently being used on a broader scale for medical and environmental applications, thereby propelling the collagen and gelatin market for regenerative medicine growth.

Market Segmentation:

By Type
•    Collagen
•    Gelatin    

By Source
•    Bovine
•    Porcine
•    Marine 
•    Others

By Application
•    Wound Care
•    Orthopaedic
•    Cardiovascular
•    Others    

By Region
•    North America
•    Europe
•    Asia-Pacific
•    Latin America
•    Middle East and Africa

The market is categorised into type, source, application and region. The type segment is fragmented into collagen and gelatin. The source segment is bifurcated into bovine, porcine ad marine. The bovine source is predicted to account the largest collagen and gelatin market for regenerative medicine share and this is mainly due to the extensive availability and lower cost of bovine products. The application segment is classified into wound care, orthopaedic, cardiovascular and other applications.  The orthopaedic segment is anticipated to lead the market, and this can be credited to the increased occurrence of osteoporosis, especially among the ageing population. The rising number of chronic wound cases shall people the growth of the wound care segment during the forecasted timeframe. Furthermore, the gelatin used for caring wounds gives a cooling effect and is also non-adhesive to wound tissues which helps in healing the wound in a shorter time and this shall help in the proliferation of the segment.

Regional Analysis:

The North America region is expected to dominate the market and tis is due to the rising prevalence of periodontitis, growing incidences of cardiovascular diseases and diabetes owing to lifestyle changes like eating oily and fast foods. However, the Asia Pacific region is predicted to showcase substantial growth during the forecasted timeframe and this is mainly due to the rising diabetic and heart disorder patients in the region, increased research and development activities and key players expanding their businesses in the region.

Competitive Landscape:                            

Some of the major market players are GELITA AG, Nitta Gelatin Inc., PB Gelatin, Royal DSM, Integra LifeSciences Holding Corporation, Collagen Solutions plc, Vornia Biomaterials Ltd., Collagen Matrix Inc., SYMATESE, NuCollagen LLC.

FutureWise Key Takeaways:

•    Growth prospects
•    SWOT analysis 
•    Key market trends 
•    Key data-points affecting market growth

Objectives of the Study:

•    To provide with an exhaustive analysis on the global collagen and gelatin market for regenerative medicine market by type, by source, by application and by region
•    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•    To evaluate and forecast micro-markets and the overall market 
•    To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
•    To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

•    We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•    The customization Mobility Care offered are free of charge with purchase of any license of the report
•    You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
           1.1 Objectives of the Study 
           1.2 Market Definition 
           1.3 Market Scope 
                1.3.1 Years Considered for the Study
                1.3.2 Market Covered
           1.4 Currency
           1.5 Limitations 
           1.6 Stakeholders 

2.  Research Methodology 
           2.1 Research Data 
                 2.1.1 Secondary Data
                         2.1.1.1 Key Data from Secondary Sources
                 2.1.2 Primary Data
                         2.1.2.1 Key Data from Primary Sources
           2.2 Market Size Estimation 
           2.3 Market Breakdown and Data Triangulation 
           2.4 Assumptions for the Study  

3. Executive Summary
           3.1 Market Outlook
           3.2 Segment Outlook
           3.3 Competitive Insights

4. Market Variables, Trends & Scope
           4.1 Market Lineage Outlook
           4.2 Penetration and Growth Prospect Mapping
           4.3 Industry Value Chain Analysis
           4.4 Cost Analysis Breakdown
           4.5 Technology Overview
           4.6 Regulatory Framework on Country Level
                4.6.1 Reimbursement Framework    
                4.6.2 Standards and Compliances

5. Market Overview
          5.1 Market Dynamics
             5.1.1 Market Driver Analysis         
             5.1.2 Market Restraint Analysis         
             5.1.3 Industry Challenges                   

6. Market Analysis tools                       
          6.1 Industry Analysis - Porter’s
                     6.1.1 Supplier Power
                     6.1.2 Buyer Power
                     6.1.3 Substitution Threat
                     6.1.4 Threat from new entrants
                     6.1.5 Competitive Rivalry                  
         6.2 Pestel Analysis
                     6.2.1 Political Landscape
                     6.2.2 Environmental Landscape
                     6.2.3 Social landscape
                     6.2.4 Technology landscape
                     6.2.5 Legal Landscape

7. Collagen and Gelatin Market for Regenerative Medicine Market, By Type Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
         7.1 Collagen
         7.2 Gelatin                        

8. Collagen and Gelatin Market for Regenerative Medicine Market, By Source Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
         8.1 Bovine 
         8.2 Porcine
         8.3 Marine 
         8.4 Others          

9. Collagen and Gelatin Market for Regenerative Medicine Market, By Application Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
         9.1 Wound Care
         9.2 Orthopaedic
         9.3 Cardiovascular
         9.4 Others        

10. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
         10.1. Introduction
         10.2. Historical Market Size (USD Mn) Analysis By Country, 2015-2019
                10.2.1. U.S.
                10.2.2. Canada
                10.2.3. Mexico 
                10.2.4. Rest of North America
         10.3 Market Size (USD Mn) Forecast for North America 2020-2027

11. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
         11.1. Introduction
         11.2. Regional Market Trends
         11.3. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019
                11.3.1. Brazil
                11.3.2. Venezuela
                11.3.3. Argentina
                11.3.4. Rest of Latin America
         11.4 Market Size (US$ Mn) Forecast for Latin America 2020-2027

12. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
         12.1. Introduction
         12.2. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019
                12.2.1. Germany
                12.2.2. U.K
                12.2.3. France
                12.2.4. Italy
                12.2.5 Switzerland
                12.2.6. Spain
                12.2.7. Russia
                12.2.8. Poland
                12.2.9. Rest of Western Europe
           12.3 Market Size (US$ Mn) Forecast for Europe 2020-2027

13. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
            13.1 Introduction
            13.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019
                 13.2.1 Japan
                 13.2.2 China
                 13.2.3 Singapore
                 13.2.4 Korea         
                 13.2.5 India
                 13.2.6 Australia and New Zealand
                 13.2.7 ASEAN
                 13.2.8 Rest of Asia Pacific
             13.3 Market Size (US$ Mn) Forecast for Asia Pacific 2020-2027

14. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    14.1 Introduction
    14.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019
           14.2.1 UAE
           14.2.2 South Africa
           14.2.3 Egypt
           14.2.4 Saudi Arabia
           14.2.5 Rest of MEA
    14.3 Market Size (US$ Mn) Forecast for MEA 2020-2027

15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
    15.1 GELITA AG
            15.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.1.2. Product Portfolio
            15.1.3. SWOT Analysis
            15.1.4. Financial Overview
            15.1.5. Strategic Overview
    15.2 Nitta Gelatin Inc.
              15.2.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.2.2. Product Portfolio
              15.2.3. SWOT Analysis
              15.2.4. Financial Overview
              15.2.5. Strategic Overview
    15.3 PB Gelatin
              15.3.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.3.2. Product Portfolio
              15.3.3. SWOT Analysis
              15.3.4. Financial Overview
              15.3.5. Strategic Overview
    15.4 Royal DSM
             15.4.1. Company Overview (HQ, Business Segments, Employee Strength)
             15.4.2. Product Portfolio
             15.4.3. SWOT Analysis
             15.4.4. Financial Overview
             15.4.5. Strategic Overview
    15.5 Integra LifeSciences Holding Corporation
              15.5.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.5.2. Product Portfolio
              15.5.3. SWOT Analysis
              15.5.4. Financial Overview
              15.5.5. Strategic Overview
    15.6 Collagen Solutions plc
              15.6.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.6.2. Product Portfolio
              15.6.3. SWOT Analysis
              15.6.4. Financial Overview
              15.6.5. Strategic Overview
    15.7 Vornia Biomaterials Ltd.
             15.7.1. Company Overview (HQ, Business Segments, Employee Strength)
             15.7.2. Product Portfolio
             15.7.3. SWOT Analysis
             15.7.4. Financial Overview
             15.7.5. Strategic Overview
    15.8 Collagen Matrix Inc.
              15.8.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.8.2. Product Portfolio
              15.8.3. SWOT Analysis
              15.8.4. Financial Overview
              15.8.5. Strategic Overview    
    15.9 Symatese
              15.9.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.9.2. Product Portfolio
              15.9.3. SWOT Analysis
              15.9.4. Financial Overview
              15.9.5. Strategic Overview
    15.10 NuCollagen LLC.
              15.10.1. Company Overview (HQ, Business Segments, Employee Strength)
              15.10.2. Product Portfolio
              15.10.3. SWOT Analysis
              15.10.4. Financial Overview
              15.10.5. Strategic Overview

16. Impact of COVID-19
      16.1. Positive influence on the healthcare industry
      16.2. The financial disruption of the manufacturing sector
      16.3. Impact of COVID-19 on emerging companies
      16.4. Significant mandates in the healthcare regulations initiated by administrations
      16.5. The overall economic slowdown of the developing and developed nations

17. Competitive Intelligence and Competitive Matrix
      17.1 Competitive Intelligence
      17.2 Competitive Matrix

18. Major Deals and Strategic Alliances Analysis
      18.1 Joint ventures
      18.2 Mergers and acquisitions              
      18.3 Licensing and partnerships
      18.4 Technology Collaborations
      18.5 Strategic Divestments
      18.6 Market Entry Strategies                        

19. Relevant Case Studies and Latest News Updates

20. Research Sources and List of Primary Contacts of this Study

21. Key Market Takeaway Points from the Market Analysts at Future Market Analytics

Tables

Figures